Continuing Education Company 29th Annual Hypertension, Diabetes, & Dyslipidemia Conference 2025

• Target Audience: physicians specializing in: family or general practice, internal medicine, endocrinology, geriatric medicine, lipidology, hypertension
• Sample video: contact me for sample video
• Information:

29th Annual Hypertension, Diabetes, & Dyslipidemia Conference

The target audience for the 29th Annual Hypertension, Diabetes, & Dyslipidemia Conference in 2025 includes a wide range of healthcare professionals who manage patients with these chronic conditions:

Primary Attendees

Physicians specializing in:

Family or General Practice

Internal Medicine

Endocrinology

Geriatric Medicine

Lipidology

Hypertension

Advanced Practice Providers:

Nurse Practitioners (NPs)

Physician Assistants (PAs)

Focus Areas

Clinical updates and treatment strategies for:

Hypertension

Diabetes

Dyslipidemia

Controversies and evolving guidelines in chronic disease management

Improving patient outcomes through evidence-based care

• Topics:

*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below

Day 1, June 18, 2025.mp4

Day 2, June 19, 2025.mp4

Day 3, June 20, 2025.mp4

* Detail:

WEDNESDAY, June 18, 2025

Welcome

A. Mullins, CMP &J. Basile, MD

Updates on the Standards of Diabetes Care

T. Garvey, MD

Pharmacotherapy of Obesity

M. Cornier, MD

Treatment to Improve Cardiometabolic Disease Outcomes: A Focus on HFpEF and Metabolic Dysfunction-Associated Steatohepatitis

T. Garvey, MD

10:15 am

BREAK

Cardiovascular Disease Risk Mitigation in Outpatient Diabetes

M. Cornier, MD

Questions for the Faculty

M. Cornier, MD & T. Garvey, MD

Cases in Diabetes, Obesity and Cardiometabolic Disease

M. Cornier, MD & T. Garvey, MD

THURSDAY, June 19, 2025

Welcome

A. Mullins, CMP

An Update on Secondary Hypertension

J. Basile MD

New Approaches to Blocking Aldosterone and Angiotensinogen for Hypertension or CKD

K. Tuttle, MD

Hypertension in the Older Patient: Is < 130 mm Hg Still the Target?

D. Jones, MD

10:30 am

BREAK

GLP-1 Receptor Agonism in the Renaissance of CKD Care

K. Tuttle, MD

Managing Stage 1 Hypertension in the Young, Low-Risk Adult

D. Jones, MD

Questions for the Faculty

J. Basile, MD, K. Tuttle, MD & D. Jones, MD

12:30 pm

LUNCH BREAK (Working Lunch)

Hypertension Cases

J. Cluett, MD & All Day 2 Faculty

FRIDAY, June 20, 2025

Welcome

A. Mullins, CMP

J. Basile, MD

Primary Prevention of CV Disease: Using our PREVENTion Tools to Improve Outcomes

S. Martin, MD

Non-Statin Agents in Primary Prevention for ASCVD Risk Reduction

J. Underberg, MD

Controversial Issues in Lipidology

S. Martin, MD

10:15 am

BREAK

Lipoprotein(a): What We Know, What We Do Not Know and What We Will Know Soon

J. Underberg, MD

Questions for the Faculty

S. Martin, MD & J. Underberg, MD

Lipid Cases

S. Martin, MD & J. Underberg, MD